SOAR Act of 2025

HR1262 — Mikaela Naylon Give Kids a Chance Act

Speeds and strengthens pediatric cancer drug development. It expands which cancer products companies must study in children, reshapes organ transplant network governance and fees, and adds new FDA international and transparency steps. - Children with cancer and researchers: Requires pediatric studies that produce clinically meaningful data on dosing, safety, and early effectiveness and widens the kinds of drug combinations studied. It also sets aside $25 million for pediatric drug studies in each of fiscal years 2026, 2027, and 2028. - Transplant patients and transplant network members: Changes Organ Procurement and Transplantation Network governance and financing by allowing quarterly registration fees, requiring those fees fund OPTN operations, improving electronic health record integration, and calling for a GAO review within two years. - FDA partners and drug makers: Creates an Abraham Accords Office to boost regulatory coordination and technical assistance abroad, and forces more transparency during generic (ANDA) reviews about whether generics are qualitatively and quantitatively the same as listed drugs. It also raises the Medicare Improvement Fund amount from $1.4 billion to $2.6 billion. Increases federal outlays by roughly $1.3 billion, driven by a $1.2 billion boost to the Medicare Improvement Fund and $75 million for pediatric studies, adding to federal spending.

HR909 — Crime Victims Fund Stabilization Act of 2025

Would make the False Claims Act apply to deposits to the Crime Victims Fund through FY2029. It would also require an Inspector General audit that sets the audit's scope, timing, and recipients, and the measure is titled the Crime Victims Fund Stabilization Act of 2025. - Entities that make deposits to the Crime Victims Fund would be subject to the False Claims Act (31 U.S.C. 3729–3731) for deposits from enactment through FY2029. - An Inspector General audit would examine the Crime Victims Fund and the bill would set the audit's scope, timing, and who receives the report.

HR842 — Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

Would expand Medicare to cover multi-cancer early detection screening tests. It defines eligible tests as certain FDA-cleared or approved genomic blood tests or comparable biological-sample tests and directs the Secretary to use the national coverage determinations process to decide when they are covered.

HR3514 — Improving Seniors’ Timely Access to Care Act of 2025

Standardize prior authorization in Medicare Advantage plans to make approvals faster and more transparent for beneficiaries and providers. The bill would require plans that use prior authorization to adopt a secure electronic PA program, publish plan-level PA data, and follow federal timeframes and enrollee protections.

HR4206 — CONNECT for Health Act of 2025

Expands Medicare telehealth access by removing geographic limits and ending an in-person requirement for telemental health. It would also change payment rules for clinics and require more oversight, training, and data reporting. - Medicare beneficiaries would be able to receive telehealth across geographies beginning October 1, 2025. Telemental health would no longer require a six-month in-person visit and tribal and Native Hawaiian facilities would be exempt from originating-site rules starting January 1, 2026. - Federally Qualified Health Centers and Rural Health Clinics would be paid for telehealth under outpatient or prospective payment methods and telehealth costs as distant-site care would count as allowable PPS costs. The HHS Secretary could waive limits on which practitioner types may furnish telehealth starting October 1, 2025 with annual public comment and a three-year reassessment requirement. - The bill would strengthen program integrity funding for telehealth, require CMS to post quarterly telehealth data, and add telehealth to quality-measure reviews within 180 days. It also mandates a beneficiary engagement study and a Government Accountability Office report on hospice recertification within three years.

HR879 — Medicare Patient Access and Practice Stabilization Act of 2025

Temporarily boosts Medicare payments to physicians and other practitioners by 6.62% for services furnished on or after April 1, 2025 and before January 1, 2026. It also updates statute language so 2025 is included in the program’s payment‑update rules. - Physicians and other practitioners: Receives a temporary 6.62% increase to Medicare payments for covered services during the specified period. - Statutory alignment: Replaces listed years with the range "2021 through 2025" so the 2025 period is applied consistently in the law.